HALO logo
halo search icon
Alector, Inc.

US$2.21

Price Change Indicator
0.09 (4.24%)
Alector, Inc.
ALEC · NAS

Alector, Inc.

Start Trading ALEC for Free

US$2.21

Price Arrow0.09 (4.24%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)HALO AllHALO Earnings MomentumHALO MomentumHammer BullishHammer Bullish (Realtime)+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alector, Inc. Overview

ALEC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ALEC

icon
icon

Telephone

1.415.231.5660

icon

Address

Suite 600, 131 Oyster Point Boulevard, South San Francisco, CA 94080-2029

Description

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

ALEC Price Chart

Key Stats

Market Cap

US$235.37M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.09 - 3.4

Trade Value (12mth)

US$643,358.00

1 week

-1.85%

1 month

-13.47%

YTD

38.56%

1 year

61.83%

All time high

43.32

Key Fundamentals

EPS 3 yr Growth

-14.20%

EBITDA Margin

-646.90%

Operating Cashflow

-$184m

Free Cash Flow Return

-168.80%

ROIC

-131.10%

Interest Coverage

0.00

Quick Ratio

3.80

Other Data

Shares Outstanding (Fully Diluted)

111m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ALEC Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

ALEC Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.56-1.23-1.39locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.56-1.23-1.39locklocklock
Growth
 %locklocklocklock3.720.9-12.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alector, Inc. (ALEC:NAS)?
Halo FAQ
The current share price of Alector, Inc. (ALEC:NAS) is USD$2.21.
What is the 52-week high share price for Alector, Inc. (ALEC:NAS)?
Halo FAQ
The 52-week high share price for Alector, Inc. (ALEC:NAS) is USD$3.40.
What is the 52-week low share price for Alector, Inc. (ALEC:NAS)?
Halo FAQ
The 52-week low share price for Alector, Inc. (ALEC:NAS) is USD$1.09.
What is the dividend yield for Alector, Inc. (ALEC:NAS)?
Halo FAQ
Alector, Inc. (ALEC:NAS) does not pay a dividend.
What was Alector, Inc. (ALEC:NAS) last dividend payment?
Halo FAQ
Alector, Inc. (ALEC:NAS) does not pay a dividend.
What is the franking level for Alector, Inc. (ALEC:NAS)?
Halo FAQ
Alector, Inc. (ALEC:NAS) has a franking level of 0.00%.
In which sector is Alector, Inc. (ALEC:NAS) classified?
Halo FAQ
Alector, Inc. (ALEC:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial